2021

1. Iwami D, Matsumoto T, Ono K, Hotta K, Ota M, Chiba Y, Sasaki H, Hirose T, Higuchi H, Takada Y,Iwahara N, Murai S, Shinohara N: Novel double-filtration plasmapheresis preserves fibrinogen while removing
immunoglobulin-G antibodies before ABO blood type-incompatible kidney transplantation. Renal
Replacement Therapy. 2021 7 (1): doi: https://doi.org/10.1186/s41100-021-00379-z. [5y-IF: N/A]
2. Konno M, Osawa T, Hotta K, Shimizu A, Abe T, Matsumoto R, Kikuchi H, Shinohara N: Primary renal
leiomyosarcoma with a tumor thrombus in the inferior vena cava. IJU Case Rep. 2021 Nov; 5 (1): 66-69.
[5y-IF: N/A]

2022
1. Ebina K, Abe T, Hotta K, Higuchi M, Furumido J, Iwahara N, Kon M, Miyaji K, Shibuya S, Lingbo Y, Komizunai
S, Kurashima Y, Kikuchi H, Matsumoto R, Osawa T, Murai S, Tsujita T, Sase K, Chen X, Konno A, Shinohara
N: Objective evaluation of laparoscopic surgical skills in wet lab training based on motion analysis andmachine learning. Langenbecks Arch Surg. 2022 Aug; 407 (5): 2123-2132. [5y-IF: 3.116]

2. Hayashi A, Yamamoto I, Kawabe M, Kobayashi A, Ito M, Hotta K, Shinohara N, Tasaki T, Yokoo T, Iwami D:
CASE REPORT: Serial Cases of False-Positive Flow- Cytometry T Cell Crossmatch Associated With AntiBlood Type Antibodies in Patients Undergoing ABO-Incompatible Kidney Transplantation. Front Immunol.
2022 Mar; 13: 862652. [5y-IF: 8.876]
3. Hayashi A, Okamoto T, Nio-Kobayashi J, Iwahara N, Suzuki R, Ueda Y, Takahashi T, Yasuyuki S,
Iwanaga T, Hotta K: CD44 as a pathological marker for the early detection of calcineurin inhibitor-induced
nephrotoxicity post kidney transplantation. Biomed Res(Tokyo). 2022 43 (5): 181-186. [5y-IF: 4.308]
4. Hirose T, Hotta K, Harada H, Tanabe T, Sasaki H, Shinohara N: Vesicoureteral reflux treatment following
kidney transplantation potentially prevents graft function deterioration and allows long-term graft survival.
Int J Urol. 2022 Jul; 29 (7): 699-706. [5y-IF: 3.011]
5. Hirose T, Hotta K, Shinohara N: Response to Re: Vesicoureteral reflux treatment following kidneytransplantation potentially prevents graft function deterioration and allows long-term graft survival.
Int J Urol. 2022 Oct; 29 (10): 1245-1246. [5y-IF: 3.011]
6. Hotta K, Hirose T, Kawai T: Clinical trials for renal allograft tolerance induction through combined

hematopoietic stem cell transplantation: A narrative review. Int J Urol. 2022 Sep 13; doi:
10.1111/iju.15035. [5y-IF: 3.011]
7. Ebina K, Abe T, Hotta K, Higuchi M, Furumido J, Iwahara N, Kon M, Miyaji K, Shibuya S, Lingbo Y,Komizunai S, Kurashima Y, Kikuchi H, Matsumoto R, Osawa T, Murai S, Tsujita T, Sase K, Chen X,Konno A, Shinohara N: Automatic assessment of laparoscopic surgical skill competence based onmotion metrics. PLoS One. 2022 Nov; 17 (11): e0277105. [5y-IF: 4.069]
8. Rosales I, Mahowald G, Tomaszewski K, Hotta K, Iwahara N, Otsuka T, Tsuji T, Takada Y, Acheampong

E, Araujo-Medina M, Bruce A, Rios A, Cosimi AB, Elias N, Kawai T, Gilligan H, Safa K, Riella L, TolkoffRunim N, Williams W, Colvin R: Banff Human Organ Transplant Transcripts Correlate with Renal
Allograft Pathology and Outcome: Importance of Capillaritis and Subpathologic Rejection. Journalof american society of nephrology. 2022 Sep; doi: https://doi.org/10.1681/ASN.2022040444. [5y-IF:12.796]
9. Tasaki M, Tateno H, Sato T, Tomioka A, Kaji H, Narimatsu H, Saito K, Nakagawa Y, Aoki T, Kamimura

M, Ushiki T, Okada M, Miwa Y, Hotta K, Yoshida Y, Takahashi K, Tomita Y: A Novel Method of CD31Combined ABO Carbohydrate Antigen Microarray Predicts Acute Antibody-Mediated Rejection in
ABO- Incompatible Kidney Transplantation. Transpl Int. 2022 Mar; 35: 10248. [5y-IF: 4.008]
10. Ueda Y, Okamoto T, Sato Y, Hayashi A, Takahashi T, Kamada K, Honda S, Hotta K: Kidneytransplantation after peritoneal dialysis-associated peritonitis and abdominal abscesses caused byMycobacterium massiliense: lesson for the clinical nephrologist. J Nephrol. 2022 Sep; 35 (7): 19071910. [5y-IF: 4.206]
11. Yamada R, Morikawa K, Hotta K, Iwami D, Tanabe T, Murai S, Shinohara N, Yoshida S, Hosoda S, KuboA, Tokuchi Y, Kitagataya T, Kimura M, Yamamoto K, Nakai M, Sho T, Suda G, Natsuizaka M, Ogawa K,
Sakamoto N: Incidence of post-transplant hepatitis B virus reactivation with the use of kidneys fromdonorswith resolved hepatitis B virus infection. J Viral Hepat. 2022 Aug; doi:10.1111/jvh.13740. [5yIF: 3.430]